The projections come as National Cancer Institute data notes an increase in uterine cancer cases and deaths over the past 30 ...

While incidence and mortality rates for most cancer types have been on the decline in the United States, cases of uterine ...

Uterine cancer incidence and mortality rates are projected to increase significantly over the next three decades in the ...

Personalized care may hold the key as survival in advanced endometrial cancer remains poor regardless of surgery type or ...

In TP53 wild-type advanced or recurrent endometrial cancer, selinexor improved multiple time-to-event outcomes vs placebo.

June is Uterine Cancer Awareness Month, and it's a crucial time to spotlight the warning signs of this increasingly deadly disease.Mandy Gaither reported that ...

In this video, Susana M. Campos, MD, MPH, discusses new research on adding metformin to letrozole/abemaciclib for the treatment of estrogen receptor-positive, recurrent endometrial cancer.The data ...